Quantum Biopharma Ltd (QNTM) Stock Price, Quote & News

Company Profile

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company's lead compound is Lucid-MS, a patented new chemical enti...

Industry: Biotechnology

Sector: Healthcare

Phone: 833 571 1811

Website: www.quantumbiopharma.com

Address:

1 Adelaide Street East, Suite 801, Toronto, Canada

Vapor83 Aug. 8 at 3:51 AM

$QNTM $9 by 9/1

0 · Reply

NetworkNewsWire Aug. 7 at 6:34 PM

MissionIRNewsBreaks – $QNTM $QNTM.CN Advances Two-Pronged Approach to Neurological Health https://ibn.fm/Cn4nf

0 · Reply

Flippinn_Stockz Aug. 7 at 5:26 PM

$NRXP $OABI $QNTM $VIVS $VSA VIVS moviiinggg .355 right now

0 · Reply

Flippinn_Stockz Aug. 7 at 4:49 PM

$NRXP $OABI $QNTM $VIVS $VSA VIVS?🐳🍉🤯 Red to green? If it breaks .33 Its over for the shorts 100 percent

0 · Reply

Flippinn_Stockz Aug. 7 at 4:44 PM

$NEXR $QNME $QNRX $QNTM $VIVS VIVS ctb rate is insaneeee🤯💣🐳

0 · Reply

Flippinn_Stockz Aug. 7 at 4:41 PM

$NEXR $QNME $QNRX $QNTM $VIVS VIVS also can run….

0 · Reply

Zeestallion Aug. 7 at 4:26 PM

$VIVS now load up Here's why 👇 screenshot 👇 $QNME $QNRX $QNTM $NEXR

1 · Reply

Zeestallion Aug. 7 at 4:25 PM

$VIVS Massive catalyst here 500%+ Revenue Growth still intact Big pharma Eli Lilly still paying China market captured Balance sheet heavy cash $QNME 🎯✅️💰✅️ we get in early folks $QNRX $QNTM $NEXR

1 · Reply

Zeestallion Aug. 7 at 4:17 PM

$VIVS 🐂💰🚀 **NAMkind Liver Model What it actually does** ✅ Detects early liver toxicity **before** preclinical failure ✅ **87.5% sensitivity** to known DILI-causing drugs ✅ **100% specificity** (rules out false positives) **Built with real human biology:** 🔹 Primary hepatocytes 🔹 Kupffer cells (immune response) 🔹 Stellate cells (fibrosis signals) 🔹 Endothelial cells **Why it matters:** Traditional animal models miss a lot. This one is designed for human relevant answers inflammation, fibrosis, and multi pathway toxicity. Aligned with FDA’s NAM framework. Built to reduce late-stage failures. $OABI $VSA $NRXP $QNTM

0 · Reply

jpurr Aug. 7 at 3:24 PM

$QNTM

0 · Reply

Quantum BioPharma Announces Closing of Debt Settlement

Mon, 20 Jul 2026 19:00:00 -0400 - 18 days ago

Quantum BioPharma Announces Intention to Settle Debt

Tue, 07 Jul 2026 19:00:00 -0400 - 4 weeks ago

Quantum BioPharma Provides Corporate Update

Fri, 26 Jun 2026 08:30:00 -0400 - 6 weeks ago

NetworkNewsAudio Announces Audio Press Release (APR) the Advancement of First-in-Class Treatment for Multiple Sclerosis

Thu, 25 Jun 2026 08:30:00 -0400 - 6 weeks ago

Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy

Tue, 23 Jun 2026 08:30:00 -0400 - 6 weeks ago

Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach

Tue, 02 Jun 2026 08:00:00 -0400 - 2 months ago

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd.

Tue, 02 Jun 2026 07:40:00 -0400 - 2 months ago

Quantum BioPharma Engages Stocks.news For Investor Relations, Marketing Services And Lead Generation Campaigns

Mon, 01 Jun 2026 19:30:00 -0400 - 2 months ago

Quantum BioPharma Provides Corporate Update

Mon, 18 May 2026 03:00:00 -0400 - 2 months ago

Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital

Thu, 07 May 2026 07:00:00 -0400 - 3 months ago

Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026

Mon, 27 Apr 2026 19:45:00 -0400 - 3 months ago

Quantum BioPharma Provides Corporate Update

Wed, 22 Apr 2026 09:16:00 -0400 - 3 months ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant

2026-04-01T12:25:14.000Z - 4 months ago

Quantum BioPharma submits Lucid-21-302 new drug application to the FDA

Wed, 01 Apr 2026 08:02:00 -0400 - 4 months ago

Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis

2026-03-30T12:47:57.000Z - 4 months ago

Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial

2026-03-30T12:28:19.000Z - 4 months ago

Quantum BioPharma signs letter of intent with Allucent to conduct Lucid-MS trial

Mon, 30 Mar 2026 07:50:00 -0400 - 4 months ago

Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis

Fri, 27 Mar 2026 19:30:00 -0400 - 4 months ago

Quantum Biopharma Provides Corporate Update

Fri, 27 Mar 2026 08:10:00 -0400 - 4 months ago

Quantum Biopharma's 2025 Audited Year End Financial Results Maintain ‘No Going Concern' Status

Mon, 23 Mar 2026 08:24:00 -0400 - 4 months ago

Quantum BioPharma Announces Peer-Reviewed Journal Publication of Groundbreaking Clinical Trial With Unbuzzd

Fri, 20 Mar 2026 19:35:00 -0400 - 5 months ago

Quantum Biopharma Announces Closing of Initial Tranche of Private Placement Offering

Wed, 11 Mar 2026 19:55:00 -0400 - 5 months ago

Quantum BioPharma Provides Corporate Update

Thu, 19 Feb 2026 19:29:00 -0500 - 6 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

Thu, 19 Feb 2026 12:00:00 -0500 - 6 months ago

Bronstein, Gewirtz & Grossman LLC Urges Quantum Biopharma Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

Tue, 17 Feb 2026 13:55:00 -0500 - 6 months ago

Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma, Ltd. Investors

Tue, 17 Feb 2026 12:59:00 -0500 - 6 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Tue, 17 Feb 2026 09:41:00 -0500 - 6 months ago

Portnoy Law Firm Announces Class Action on Behalf of Quantum Corporation Investors

Thu, 12 Feb 2026 16:02:00 -0500 - 6 months ago

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines - QNTM

Tue, 03 Feb 2026 13:12:00 -0500 - 6 months ago

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Mon, 02 Feb 2026 10:46:00 -0500 - 6 months ago

Portnoy Law Firm Announces Class Action on Behalf of Quantum Biopharma Ltd. Investors

Tue, 27 Jan 2026 13:42:00 -0500 - 6 months ago

CONTACT: INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Quantum Biopharma Ltd. of Class Action Lawsuit and Upcoming Deadlines – QNTM

Dec 23, 2025, 8:00 AM EST - 8 months ago

Quantum Biopharma Announces Completion of Dosing in 180-Day Repeated Dose Oral Toxicity and Toxicokinetic Studies for Lucid-21-302 (Lucid-MS)

Mon, 22 Dec 2025 09:00:00 -0500 - 8 months ago

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares

Dec 10, 2025, 8:00 PM EST - 8 months ago

Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update

2025-12-01T12:15:18.000Z - 8 months ago

Quantum BioPharma announces airing of news segment on manipulation lawsuit

Nov 27, 2025, 4:00 PM EST - 9 months ago

Award-winning Investigative News Program W5 Airs Part 2 of 3-part Television Series on Alleged Stock Market Manipulation of Quantum Biopharma Involving Two of Canada's Largest Banks, CIBC and RBC

Nov 26, 2025, 9:30 AM EST - 9 months ago

Quantum Biopharma's USD $700 Million Lawsuit Alleging Stock Market Manipulation Subject of 3-part Series Investigative News Program W5

2025-11-07T12:12:42.000Z - 9 months ago

Quantum BioPharma reports Q3 EPS ($1.25) vs. (4.37) last year

2025-11-07T12:11:35.000Z - 9 months ago

Quantum BioPharma sees cash runway beyond March 2027

Nov 7, 2025, 7:00 AM EST - 9 months ago

Quantum Biopharma Reports Strong Third Quarter Results Maintaining ‘No Going Concern' Status with Cash Runway Extending Beyond March 2027, and $572,000 USD Gains in Crypto Portfolio

Oct 31, 2025, 7:51 PM EDT - 10 months ago

Quantum BioPharma Ltd. Provides Corporate Update

Oct 29, 2025, 9:00 PM EDT - 10 months ago

Quantum BioPharma Ltd. Announces Corporate Updates

Oct 23, 2025, 8:15 AM EDT - 10 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar for its Disruptive Beverage Innovation that Speeds Alcohol Metabolism, Reduces Symptoms of Intoxication

2025-10-20T12:40:40.000Z - 10 months ago

Quantum BioPharma announces expiration of warrants held by hedge funds

Oct 20, 2025, 8:30 AM EDT - 10 months ago

Quantum BioPharma Ltd. Announces Expiration of All Warrants Held by Hedge Funds and Re-Iterates October 27, 2025, Record Date for the Distribution of a Special Dividend

Oct 14, 2025, 8:15 AM EDT - 10 months ago

Quantum BioPharma Ltd. Responds to Vague and Misleading Allegations by The Schall Law Firm and DJS Law Group

Oct 9, 2025, 6:00 PM EDT - 10 months ago

Quantum BioPharma Ltd. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – QNTM

Oct 9, 2025, 5:40 PM EDT - 10 months ago

QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm

2025-10-08T12:15:28.000Z - 10 months ago

Quantum BioPharma offers cash reward up to $7M for market manipulation proof

Oct 8, 2025, 8:00 AM EDT - 10 months ago

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Oct 7, 2025, 11:00 AM EDT - 10 months ago

Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View

2025-10-03T11:10:25.000Z - 11 months ago

Quantum BioPharma announces record date for special dividend distribution

Oct 3, 2025, 7:00 AM EDT - 11 months ago

Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case

2025-10-02T12:00:38.000Z - 11 months ago

Quantum BioPharma receives final reports for two studies of Lucid-21-302

Oct 2, 2025, 7:57 AM EDT - 11 months ago

Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial

Oct 1, 2025, 7:50 AM EDT - 11 months ago

Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials

Sep 29, 2025, 7:40 AM EDT - 11 months ago

Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders

Sep 26, 2025, 8:00 PM EDT - 11 months ago

Quantum BioPharma Announces Corporate Updates

Sep 24, 2025, 8:30 AM EDT - 11 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Live Webinar and Q&A Session on Wednesday, October 1, 2025

Sep 18, 2025, 8:10 AM EDT - 11 months ago

Health Canada Grants Quantum BioPharma a Product License for Its Innovative Product, Qlarity™, that Enhances Energy, and Promotes Metabolism, Mental Alertness and Cognitive Performance

Sep 12, 2025, 7:50 AM EDT - 11 months ago

Quantum BioPharma Licensee Unbuzzd Wellness to Host Investor Webinar on September 16, 2025 at 1:30 PM PT

Sep 10, 2025, 7:00 AM EDT - 11 months ago

Kingswood Capital Partners Initiates Analyst Coverage on Quantum BioPharma with a BUY Rating and US$45 Price Target

Aug 11, 2025, 6:32 PM EDT - 1 year ago

Quantum BioPharma Announces Update to Previously Announced Private Placement

Aug 11, 2025, 7:40 AM EDT - 1 year ago

Quantum BioPharma Signs Agreement to Manufacture Oral Drug Formulation of its Potential Breakthrough Drug Lucid-21-302 (Lucid-MS) for Use in its Upcoming Phase 2 Multiple Sclerosis Trial

Aug 8, 2025, 8:00 AM EDT - 1 year ago

Quantum BioPharma Announces Very Promising Results from the Massachusetts General Hospital Scientists on the Novel Positron Emission Tomography (PET) Tracer Used to Detect and Monitor Demyelination in Multiple Sclerosis Patients

Aug 7, 2025, 7:00 AM EDT - 1 year ago

Quantum Biopharma Reports Strong Second Quarter with Increased Current and Total Assets, Conversion of all Debentures into Equity, Continued Exclusion of Going Concern, Tripling of Share Price during Quarter, over $500,000 USD Gain in Crypto Assets as of date of filing, and Near Elimination of Debt

Aug 5, 2025, 7:34 AM EDT - 1 year ago

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)

Aug 4, 2025, 7:33 AM EDT - 1 year ago

Quantum BioPharma Files Reply and Provides Update on Court Case Seeking Damages Against CIBC, RBC and Others in Excess of $700,000,000 USD for Possible Stock Price Manipulation/Spoofing

Jul 31, 2025, 7:24 AM EDT - 1 year ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Commences Reg D Capital Raise Campaign to Fund Growth and Possible IPO

Jul 22, 2025, 7:00 AM EDT - 1 year ago

Quantum BioPharma Makes Strategic Investment in GameStop Corp.

GME

Jun 27, 2025, 4:30 PM EDT - 1 year ago

Quantum BioPharma Announces Private Placement

Jun 26, 2025, 7:30 AM EDT - 1 year ago

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering

Vapor83 Aug. 8 at 3:51 AM

$QNTM $9 by 9/1

0 · Reply

NetworkNewsWire Aug. 7 at 6:34 PM

MissionIRNewsBreaks – $QNTM $QNTM.CN Advances Two-Pronged Approach to Neurological Health https://ibn.fm/Cn4nf

0 · Reply

Flippinn_Stockz Aug. 7 at 5:26 PM

$NRXP $OABI $QNTM $VIVS $VSA VIVS moviiinggg .355 right now

0 · Reply

Flippinn_Stockz Aug. 7 at 4:49 PM

$NRXP $OABI $QNTM $VIVS $VSA VIVS?🐳🍉🤯 Red to green? If it breaks .33 Its over for the shorts 100 percent

0 · Reply

Flippinn_Stockz Aug. 7 at 4:44 PM

$NEXR $QNME $QNRX $QNTM $VIVS VIVS ctb rate is insaneeee🤯💣🐳

0 · Reply

Flippinn_Stockz Aug. 7 at 4:41 PM

$NEXR $QNME $QNRX $QNTM $VIVS VIVS also can run….

0 · Reply

Zeestallion Aug. 7 at 4:26 PM

$VIVS now load up Here's why 👇 screenshot 👇 $QNME $QNRX $QNTM $NEXR

1 · Reply

Zeestallion Aug. 7 at 4:25 PM

1 · Reply

Zeestallion Aug. 7 at 4:17 PM

0 · Reply

jpurr Aug. 7 at 3:24 PM

$QNTM

0 · Reply

jpurr Aug. 7 at 3:17 PM

$QNTM

0 · Reply

nealp09 Aug. 7 at 2:34 PM

$GNS at least $QNTM is doing something

0 · Reply

FickleFin Aug. 7 at 12:38 PM

$QNTM regurgitated vomit. Paid to pump. Baloney is back.

0 · Reply

Vapor83 Aug. 6 at 2:58 AM

$QNTM 10x by Nov 1

0 · Reply

FickleFin Aug. 5 at 1:40 PM

$QNTM no support... share price is being propped... just ask Kevin Baloney...lol

0 · Reply

ExploringTrades Aug. 4 at 5:19 PM

Ticker NEXR has barely 550,000 shares outstanding. The only comparable ticker was VEEE and that one ran from 4.10$ to over 51$. NEXR released news on Aug 3rd and is shifting heavily into the AI sector. NEXR has only about 700 watchers on Stocktwits. Took a big position looking to profit massively very soon. $RIME $QNTM $SEGG Long it

0 · Reply

FickleFin Aug. 3 at 1:02 PM

$QNTM $GNS nothing left for this shit stock.

0 · Reply

Merlintrader Aug. 1 at 8:53 PM

$QNTM Quantum BioPharma Stock Hub https://www.merlintrader.com/quantum-biopharma-stock-hub/

0 · Reply

NetworkNewsWire Jul. 31 at 7:41 PM

NetworkNewsBreaks – $QNTM $QNTM.CN Advances MS Imaging Study with Encouraging Preliminary Results https://nnw.fm/SZpfE

0 · Reply

FickleFin Jul. 31 at 12:33 PM

$QNTM settles debt by issuing shares... equates to dilution. They always post they have enough cash runway for future dates but somehow fall short on the reports. Spends majority of their money on digitals assets and R&D. Debt created. Investors pay off. Rinse and repeat. Where does all the money go all these years? No revenue in sight. Over promised and under delivered 100% Everytime. They've shown their cards multiple of time, then hide in silence. Just wait for another stupid press release. Regurgitated Word vomit.

0 · Reply

Rambler1111 Jul. 30 at 6:31 AM

$QNTM Riddle me this, it was said that Unbuzzed would be doing an IPO this summer with a rollout of new flavours. Was that just talk? Or was it just an off based announcement that never had a chance. QNTM and their lawsuit silent along with the MS drug doing PRs but not able to do anything due to red tape due to the FDA. 2026 looks like it will prove to be a do nothing year like 2025. IR has proven to be very quiet other than a few puff pieces with nothing new. Like this filing that they’re paying $145000 in debt just makes me think QNTM is cash poor.

1 · Reply

NetworkNewsWire Jul. 27 at 7:47 PM

BioMedNewsBreaks — $QNTM $QNTM.CN Executive Outlines Lucid-MS Development Strategy and Commercial Growth Plans https://ibn.fm/UrhDk

0 · Reply

Market Cap	20.67M
Revenue (ttm)	0.00
Net Income (ttm)	-26.18M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	181,500
Avg Vol	177,726
Day's Range	N/A - N/A
Shares Out	6.40M
Stochastic %K	76%
Beta	0.45
Analysts	Sell
Price Target	$35.50